Sunnybrook Research Institute:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Sunnybrook Research Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11220
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Sunnybrook Research Institute (SRI) an educational institute that offers medical education and research services. The institute provides undergraduate, postgraduate and doctoral degree programs. It provides research platforms for biological sciences, evaluative clinical sciences and physical sciences. SRI offers research programs for brain science, bone and joint, cancer, heart, rehabilitation, veterans, and women’s and babies. The institute provides laboratory for biomarker imaging research, biophotonics and bioengineering, bulbar function, burn research and skin, cognitive neurology and others. It operates Breast Cancer Research Centre, HOPE Research Center, Perioperative Brain Health Center. SRI is headquartered in Toronto, Ontario, Canada.

Sunnybrook Research Institute – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Sunnybrook Research Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sunnybrook Research Institute, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Sunnybrook Research Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sunnybrook Research Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Sunnybrook Research Institute, Medical Devices Deals, 2012 to YTD 2018 9
Sunnybrook Research Institute, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Sunnybrook Research Institute, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Neovacs Enters into Agreement with Sunnybrook Research Institute 11
Triphase Accelerator Enters into Agreement with Sunnybrook Research Institute 12
Kalgene Pharma Enters into Co-Development Agreement with Sunnybrook Research Institute, CIMTEC and OCBN 13
Sunnybrook Research Institute – Key Competitors 14
Sunnybrook Research Institute – Key Employees 15
Sunnybrook Research Institute – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Sunnybrook Research Institute, Pharmaceuticals & Healthcare, Key Facts 2
Sunnybrook Research Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sunnybrook Research Institute, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Sunnybrook Research Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sunnybrook Research Institute, Deals By Therapy Area, 2012 to YTD 2018 8
Sunnybrook Research Institute, Medical Devices Deals, 2012 to YTD 2018 9
Sunnybrook Research Institute, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Neovacs Enters into Agreement with Sunnybrook Research Institute 11
Triphase Accelerator Enters into Agreement with Sunnybrook Research Institute 12
Kalgene Pharma Enters into Co-Development Agreement with Sunnybrook Research Institute, CIMTEC and OCBN 13
Sunnybrook Research Institute, Key Competitors 14
Sunnybrook Research Institute, Key Employees 15
Sunnybrook Research Institute, Subsidiaries 16

List of Figures
Sunnybrook Research Institute, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Sunnybrook Research Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Sunnybrook Research Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Sunnybrook Research Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Sunnybrook Research Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sunnybrook Research Institute, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Sunnybrook Research Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sunnybrook Research Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Sunnybrook Research Institute, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Sunnybrook Research Institute:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Xencor Inc (XNCR):製薬・医療:M&Aディール及び事業提携情報
    Summary Xencor Inc (Xencor) is a clinical-stage biopharmaceutical company that develops engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases and cancer. The company provides pipeline products under preclinical development such as XmAb14045, for the …
  • Avangrid Inc (AGR):企業の財務・戦略的SWOT分析
    Avangrid Inc (AGR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Saudi Arabian Mining Co:戦略・SWOT・企業財務分析
    Saudi Arabian Mining Co - Strategy, SWOT and Corporate Finance Report Summary Saudi Arabian Mining Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Sumitomo Mitsui Construction Co Ltd (1821):企業の財務・戦略的SWOT分析
    Sumitomo Mitsui Construction Co Ltd (1821) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • Morepen Laboratories Ltd (MOREPENLAB):製薬・医療:M&Aディール及び事業提携情報
    Summary Morepen Laboratories Ltd (Morepen Laboratories) is a manufacturer and supplier of active pharma ingredients and formulations. The company offers active pharma ingredients, formulation and homehealth solutions. It offers products in forms of tablets, capsules, liquids and powders. Morepen Lab …
  • Aclaris Therapeutics Inc (ACRS):製薬・医療:M&Aディール及び事業提携情報
    Summary Aclaris Therapeutics Inc (Aclaris Therapeutics) is a dermatologist-led bio-pharmaceutical company which focuses on identifying, developing, and commercializing prescription drug products for unmet needs in aesthetic and medical dermatology as well as immunology. Its lead product, ESKATA, is …
  • Tofas Turk Otomobil Fabrikasi A.S.:企業の戦略・SWOT・財務情報
    Tofas Turk Otomobil Fabrikasi A.S. - Strategy, SWOT and Corporate Finance Report Summary Tofas Turk Otomobil Fabrikasi A.S. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Vestas Wind Systems AS (VWS):企業の財務・戦略的SWOT分析
    Vestas Wind Systems AS (VWS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Sanlam Kenya Plc:企業の戦略・SWOT・財務情報
    Sanlam Kenya Plc - Strategy, SWOT and Corporate Finance Report Summary Sanlam Kenya Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Premiere Global Services, Inc.:企業の戦略的SWOT分析
    Premiere Global Services, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Petrosibir AB (SHEL B):企業の財務・戦略的SWOT分析
    Summary Petrosibir AB (Petrosibir), formerly Shelton Petroleum AB is an oil and gas company. The company offers exploration and development of oil and gas assets and the resource-rich basins in Russia and Ukraine. It holds Ayazovskoye production license and Rustamovskoye exploration license that cov …
  • Amunix Operating Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Amunix Operating Inc (Amunix) is a biotechnology company that discovers and develops long-acting protein-based therapeutics. The company develops protein and peptide therapeutics. It uses its proprietary technology platform XTEN, a proprietary recombinant polypeptide that consists of natural …
  • Alternatifbank A.S.
    Alternatifbank A.S. - Strategy, SWOT and Corporate Finance Report Summary Alternatifbank A.S. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Asian American Medical Group Ltd (AJJ):企業の財務・戦略的SWOT分析
    Asian American Medical Group Ltd (AJJ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Summit Midstream Partners LP (SMLP):石油・ガス:M&Aディール及び事業提携情報
    Summary Summit Midstream Partners LP (SMLP) is an oil and gas company that develops, owns and operates midstream energy infrastructure assets located in unconventional shale resource basins and shale formations across North America. The company operates natural gas, crude oil, and produced water gat …
  • Nielsen Holdings plc (NLSN):企業の財務・戦略的SWOT分析
    Nielsen Holdings plc (NLSN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Cavco Industries Inc:企業の戦略・SWOT・財務情報
    Cavco Industries Inc - Strategy, SWOT and Corporate Finance Report Summary Cavco Industries Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • DiamondRock Hospitality Co:企業のM&A・事業提携・投資動向
    DiamondRock Hospitality Co - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's DiamondRock Hospitality Co Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • ProQR Therapeutics NV (PRQR):企業の財務・戦略的SWOT分析
    Summary ProQR Therapeutics NV (ProQR) is a clinical-stage biotech company that discovers and develops drugs for the treatment of genetic disorders. The company’s lead product candidate includes QR-010, a RNA-based oligonucleotide used for the treatment of cystic fibrosis; QR-110, an oligonucleotide …
  • Halewood International Holdings PLC:企業の戦略・SWOT・財務情報
    Halewood International Holdings PLC - Strategy, SWOT and Corporate Finance Report Summary Halewood International Holdings PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆